menu Search
Avicon

Avicon

olopatadine

Manufacturer:

ACME Lab

Distributor:

Euro Generics
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Olopatadine
Indications/Uses
Ocular signs & symptoms of seasonal allergic conjunctivitis.
Click to view Avicon detailed prescribing information
Dosage/Direction for Use
Adult & paed patient ≥3 yr Instill 1 drop in the conjunctival sac of the affected eye(s) bid at an interval of 8 hr. Treatment may be maintained for up to 4 mth, if considered necessary.
Click to view Avicon detailed prescribing information
Overdosage
View Avicon overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Avicon detailed prescribing information
Special Precautions
Discontinue use if signs of serious reactions or hypersensitivity occur. Contains benzalkonium Cl which may cause eye irritation & has been reported to cause punctate keratopathy &/or toxic ulcerative keratopathy. Closely monitor frequent or prolonged use in dry eye patients, or in conditions where cornea is compromised. Avoid contact w/ soft contact lenses; remove contact lenses prior to administration & wait at least 15 min after instillation before re-inserting. Allow 5-min interval between successive applications of concomitant topical ocular medicines; administer eye oint last. Not recommended during pregnancy & in women of childbearing potential not using contraception. Should not be used during breast-feeding. Safety & efficacy in childn <3 yr have not been established.
Click to view Avicon detailed prescribing information
Use In Pregnancy & Lactation
Click to view Avicon detailed prescribing information
Adverse Reactions
Rhinitis; hypersensitivity, swelling face; headache, dysgeusia, dizziness, hypoaesthesia, somnolence; eye pain, eye irritation, dry eye, abnormal sensation in eyes, corneal erosion, corneal epithelium defect, corneal epithelium disorder, punctate keratitis, keratitis, corneal staining, eye discharge, photophobia, blurred vision, reduced visual acuity, blepharospasm, ocular discomfort, eye pruritus, conjunctival follicles, conjunctival disorder, foreign body sensation in eyes, increased lacrimation, erythema of eyelid, eyelid oedema, eyelid disorder, ocular hyperaemia, corneal oedema, eye oedema, eye swelling, conjunctivitis, mydriasis, visual disturbance, eyelid margin crusting; nasal dryness, dyspnea, sinusitis; nausea, vomiting; contact dermatitis, skin burning sensation, dry skin erythema; fatigue, asthenia, malaise.
Click to view Avicon detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Avicon detailed prescribing information
Storage
View Avicon storage conditions for details to ensure optimal shelf-life.
Description
View Avicon description for details of the chemical structure and excipients (inactive components).
Action
View Avicon mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories
ATC Classification
S01GX09 - olopatadine ; Belongs to the class of other ophthalmologic antiallergics.
Regulatory Classification
Rx
Presentation/Packing
Form
Avicon ophth soln 1 mg/mL (0.1% w/v)
Packing/Price
5 mL x 1's